Related Experiment Video
Updated: Apr 14, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Heart failure in a cohort of patients with chronic kidney disease: the GCKD study
Hanna Beck1, Stephanie I Titze2, Silvia Hübner2
1Department of Medicine, Division of Nephrology, Medical Center-University of Freiburg, Freiburg, Germany.
Insights
Heart failure (HF) is highly prevalent in patients with chronic kidney disease (CKD). Early screening for HF in CKD patients is crucial due to shared risk factors and symptoms.
Area of Science:
- Nephrology
- Cardiology
- Epidemiology
Background:
- Chronic kidney disease (CKD) is a known risk factor for heart failure (HF) development and progression.
- Shared risk factors exist between CKD and HF, but data on HF prevalence in moderate CKD are limited.
Purpose of the Study:
- To investigate the prevalence and correlates of HF in the German Chronic Kidney Disease (GCKD) cohort.
- To examine HF in patients with moderate CKD severity.
Main Methods:
- Analysis of 5,015 GCKD patients (aged 18-74) with eGFR <60 ml/min/1.73m² or eGFR ≥60 with proteinuria.
- HF definition based on Gothenburg score and self-report.
- Multivariable logistic regression to identify associated factors.
Main Results:
- Prevalence of Gothenburg HF was 43% (higher in lower eGFR), and self-reported HF was 18%.
- Lower eGFR, older age, female gender, higher BMI, hypertension, diabetes, valvular heart disease, anemia, sleep apnea, and lower education were associated with HF.
- Significant independent association between lower eGFR and Gothenburg HF (p-trend <0.001).
Conclusions:
- High burden of both self-reported and Gothenburg HF in CKD patients.
- Gothenburg score may overestimate HF in CKD due to overlapping symptoms and treatments.
- Emphasizes the need for early HF screening in CKD populations.
Background And Aims:
Chronic kidney disease (CKD) is a risk factor for development and progression of heart failure (HF). CKD and HF share common risk factors, but few data exist on the prevalence, signs and symptoms as well as correlates of HF in populations with CKD of moderate severity. We therefore aimed to examine the prevalence and correlates of HF in the German Chronic Kidney Disease (GCKD) study, a large observational prospective study.
Methods And Results:
We analyzed data from 5,015 GCKD patients aged 18-74 years with an estimated glomerular filtration rate (eGFR) of <60 ml/min/1.73m² or with an eGFR ≥60 and overt proteinuria (>500 mg/d). We evaluated a definition of HF based on the Gothenburg score, a clinical HF score used in epidemiological studies (Gothenburg HF), and self-reported HF. Factors associated with HF were identified using multivariable adjusted logistic regression. The prevalence of Gothenburg HF was 43% (ranging from 24% in those with eGFR >90 to 59% in those with eGFR<30 ml/min/1.73m2). The corresponding estimate for self-reported HF was 18% (range 5%-24%). Lower eGFR was significantly and independently associated with the Gothenburg definition of HF (p-trend <0.001). Additional significantly associated correlates included older age, female gender, higher BMI, hypertension, diabetes mellitus, valvular heart disease, anemia, sleep apnea, and lower educational status.
Conclusions:
The burden of self-reported and Gothenburg HF among patients with CKD is high. The proportion of patients who meet the criteria for Gothenburg HF in a European cohort of patients with moderate CKD is more than twice as high as the prevalence of self-reported HF. However, because of the shared signs, symptoms and medications of HF and CKD, the Gothenburg score cannot be used to reliably define HF in CKD patients. Our results emphasize the need for early screening for HF in patients with CKD.
Related Concept Videos
Chronic Kidney Disease IV: Nursing Management
Heart Failure Drugs: Diuretics
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Heart Failure I: Introduction
Pathophysiology of Heart Failure

